Navigating EU HTA: Your Roadmap to Success Ep. 4

Mastering the JCA Process – A Strategic Approach

We are excited to introduce the fourth episode in our new series of short videos dedicated to exploring the intricacies and challenges of navigating the EU Health Technology Assessment (HTA) Regulation. In our previous bite-sized videos, we explored essential topics such as business readiness for the EU HTAR, PICO simulation, and the joint scientific consultation. This episode shifts our focus to the critical aspects you need to consider when navigating the Joint Clinical Assessment (JCA) process—a mandatory step under the EU HTAR that evaluates the relative efficacy and safety of new health technologies.

In this video, we offer strategic insights to help you master the JCA process. From understanding the scope and stringent evidence requirements to managing the limited interaction points available to manufacturers, we outline the key considerations to keep in mind. Our aim is to equip you with practical advice and resources so that you can successfully navigate the complexities of the JCA and ensure your submissions are both thorough and timely.